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A systematic review revealed three small randomised controlled trials of yoga for low back pain, all of
which showed effects on back pain that favoured the yoga group. To build on these studies a larger trial,
with longer term follow-up, and a number of different yoga teachers delivering the intervention is
required. This study protocol describes the details of a randomised controlled trial (RCT) to determine the
effectiveness and cost-effectiveness of Yoga for chronic Low Back Pain, which is funded by Arthritis
Research Campaign (arc) and is being conducted by the University of York. 262 patients will be recruited
from GP practices in 5 centres in England. Patients will be randomised to receive usual care or 12 weekly
classes of yoga. A yoga programme will be devised that can be delivered by yoga teachers of the twomain
national yoga organisations in the UK (British Wheel of Yoga and Iyengar Yoga Association (UK)).
Trial registration: Current controlled trials registry ISRCTN81079604 (date registered 30/03/2007).
 2009 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Background
Back pain is an extremely common and costly condition and
treatments for low back pain (LBP) tend to be unsatisfactory.
Exercise treatment, though widely used and recommended, has
only a small effect on back pain,1 and manipulation treatments,
delivered either by a physiotherapist, chiropractor or osteopath, are
better than exercise alone but are not widely available on the NHS
and are more expensive than group exercise sessions.1 An alter-
native approach to the treatment of low back painmay be the use of
yoga. Yoga offers a combination of physical exercise with mental
focus that may make it a suitable therapy for the treatment of low
back pain. A randomised controlled trial (RCT) undertaken in the
USA has shown that LBP patients allocated to yoga classes had
signiﬁcantly less pain after 12 weeks compared with those allo-
cated to an exercise control group.2 The improvement in back pain; fax: þ44 (0) 1904 321387.
john.aplin@manchester.co.uk
trewhela5099.freeserve.co.uk
linical Trials Research House,
m.
-NC-ND license.at 12 weeks was 3.4 points on the Roland and Morris back pain
scale, which was more than twice as much as that noted for
manipulation in the recent UK BEAM study1 among a similar group
of patients and at a similar follow-up time.
We have undertaken a systematic review of the Cochrane
database and the relevant research registers and at this time found
no ongoing RCTs of yoga therapy of low back pain.We did, however,
identify a total of three small published RCTs of yoga therapy for
low back pain.2–4 All three studies showed effects on back pain that
favoured the yoga group and this was statistically signiﬁcant in two
of the studies (yoga versus written material P< 0.001,2 yoga versus
exercise P¼ 0.0342; yoga versus educational control P¼ 0.0033).
Despite these encouraging results there is still need for another
trial. The main limitation with existing trials is that only one yoga
teacher delivered the intervention which makes the trial’s results
unrepresentative of all yoga teachers, therefore it is important that
several yoga teachers deliver treatment. In order to develop an
intervention with the widest possible applicability, it is also
important to gain the agreement of yoga practitioners of the most
prominent schools of yoga operating in the UK on a package of
movements that all would bewilling to deliver to patients with low
back pain. An agreed package would allow the results to be gen-
eralisable across all yoga practitioners. Existing trials as well as
H. Cox et al. / Complementary Therapies in Clinical Practice 16 (2010) 76–80 77being small also have short-term follow-up. It would be useful to
see whether the effects of yoga are longer lasting. The potential for
yoga to have a longer term inﬂuence is more likely than, for
example, manipulation, as yoga participants will be encouraged to
practise the technique at home between classes, and to continue
with home practice after the classes have been completed. It is
reasonable therefore to suppose that if participants do continue
with home practice, initial yoga training may have long-term
beneﬁts on back pain making it important that we should follow-
up a cohort of low back pain patients, after having had yoga
treatment, for at least a year to ascertain whether or not any long-
term beneﬁts are seen.
Because back pain is an excessive burden on society and is
associated with high costs, it is important that we should evaluate
any treatment that may reduce this problem. Yoga is potentially
a very cost-effective treatment as it can be delivered in group
sessions, which substantially reduces the cost per treatment for
each individual, when compared to a treatment delivered on a one-
to-one basis such as physiotherapy.
2. Trial objectives
The primary objectives of this study are to test the effectiveness
and cost-effectiveness of yoga for LBP in primary care. This will be
achieved by:
1. Producing a package of yoga care agreed by a cross-section of
yoga practitioners from different Yoga traditions, including
a written manual for yoga teachers and their students.
2. Undertake a large multi-centre RCT of the agreed yoga care
package versus usual care on patients with low back pain to
evaluate if the yoga intervention is more effective in reducing
disability due to back pain.
3. Undertaking a cost-effectiveness analysis of yoga treatment
and usual care in relation to usual care alone for LBP.3. Methods
3.1. Trial design
This study is a multi-centred pragmatic two-arm RCT which
will collect patient preference data before all patients are rando-
mised. Randomisation will be at the patient level and patients
will be randomly allocated to receive yoga or usual care. We will
recruit approximately twenty yoga teachers at ﬁve sites (Cornwall,
North London, West London, Manchester and York). These yoga
teachers will be trained in the agreed package of care.
3.2. Recruitment and participants
We plan to use a ‘database’ recruitment method as this method
has been shown to recruit large numbers of patients in a relatively
short space of time.Wewill recruit GP practices local to each site by
mailing out to them an invitation letter and an information sheet
detailing the process of the trial and what would be required of the
practice if they agreed to participate. GP practices will be
compensated for the time taken on the research and all stationary
and postage costs will be provided. Participating GP practices will
search their databases using Read Codes andmail out a recruitment
pack to all patients aged between 18 and 65 who have had
a consultation with low back pain in the last 18 months. Patients
will be asked to consider taking part in a trial of yoga therapy
for LBP. Those patients who agree will be asked to complete an
eligibility questionnaire containing the Roland and Morris backpain scale and to return this to the York Trials Unit at the University
of York. The trial co-ordinator will then assess eligibility. Patients
who score 4 or more on the measure, and meet other inclusion
criteria will be eligible to participate. One back pain trial based in
Manchester used the database recruitmentmethod and found 2068
LBP patients from 9 GP practices. Out of these 234 (11.3%) met the
inclusion criteria and were randomised.5 This trial used the data-
base method of recruitment and recruited its sample size on time.
In this study we propose to recruit 20 GP practices in case of
differential recruitment rates across the different geographical
areas, and we anticipate recruitment will take 6 months.
3.3. Inclusion and exclusion criteria
The inclusion criteria will be: aged 18–65; presented to their GP
with low back pain in the previous 18 months; a score of 4 or more
on the Roland & Morris Disability Questionnaire (RDQ); must be
physically mobile (i.e. able to climb up and down stairs, and able to
get off the ﬂoor unaided); and, indicated that they are able to attend
at least one of the yoga classes on offer.
The exclusion criteria will be: patients over 65 as they are more
likely to have serious spinal pathology; clinical indications of
serious spinal or neurological pathology as indicated by ‘warning
signs’6; pregnant women; previous spinal surgery, and; history of
psychosis or alcohol abuse (due to difﬁculty in assessing outcomes).
3.4. Randomisation and allocation
Eligible patients will be randomised remotely to either yoga or
usual care. In the trial eligibility questionnaire, participants will be
asked to specify their availability to attend yoga classes in different
regions from a list of dates and times available. Once the total
number of participants wanting to attend each yoga class is known,
then the randomisationwill beundertaken. To ensure that eachyoga
class does not exceed itsmaximum capacity, but still ensure balance
in the overall number of participants in each trial arm, unequal
allocation may be used for some classes. For example, if 24 partici-
pants speciﬁed their availability as being the yoga class in Man-
chester onMonday and themaximum capacity for this class was 15,
then a allocation ratio of 1:1.7 (9 to the control group and 15 to the
yogagroup) couldbeused. Allocation ratioswill need tobe amended
to ensurebalanceoverall and thus it is possible that someclasseswill
not reach their maximum capacity. The randomisation and alloca-
tionwill be conducted by an independent data manager in the York
Trials Unit, University of York, using a computer program. The trial
co-ordinator will write to the participants informing them of their
treatment allocation.
3.5. Interventions
The yoga intervention will consist of 12 weekly 75-min classes
(with a one or two week break at mid-course), plus education and
information for home practice. There are a number of recom-
mended yoga practices for people with low back pain, which are
delivered by teachers of different yoga traditions. Among the co-
applicants are representatives of the two largest yoga associations
within the UK: British Wheel of Yoga and Iyengar Yoga Association
(UK). Within the ﬁrst three months of the study, whilst we gain
ethics permission and NHS Research and Development approval,
we will conduct a series of meetings between experienced yoga
practitioners in order to agree on a basic package of yoga that can
be delivered by yoga teachers of these two national organisations.
Yoga teachers taking part in the study will be trained in this
package of care over two intensive training weekends. As part of
the study we will also develop a manual for yoga teachers and
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the agreed series of yoga techniques that can be readily used by
experienced yoga teachers and can be practised at home by
patients receiving yoga. A yoga mat will be given to patients.
Intervention patients will also receive any normal ongoing treat-
ments if these are deemed necessary.
The patients allocated to the control group will receive any
ongoing treatment (i.e. usual care) that they would normally
receive plus the offer of one yoga class in twelve months time after
the ﬁnal 12 month questionnaire has been completed. Both groups
will receive ‘The Back Book’6 which is an evidenced-based booklet
written by a group of international back pain experts and is aimed
at patients who have chronic low back pain.3.6. Outcomes
Clinical outcome measures will be collected via postal ques-
tionnaires at baseline, 3 months, 6 months, and 12 months follow-
up. The primary outcome measure will be functional limitations
and disability as measured by the Roland & Morris Disability
Questionnaire (RDQ).7 The RDQ consists of a 24 point scale asking
questions relating to the patients back pain and dysfunction on that
day. The minimum clinically signiﬁcant difference on the RDQ has
been estimated to range between 2 and 3 points.8–10 This scale has
been found to be sensitive to change, reliable and valid.8,9,11
Secondary outcome measures will include: Clinical status as
measured by the Aberdeen Back Pain Scale (ABPS)12; general health
status measured using the SF-1213; the EQ-5D health index; pain
self-efﬁcacy as measured by the Pain Self-Efﬁcacy Questionnaire
(PSEQ)14; HADS; simple quantifying measures of (i) number of days
spent in bed due to back pain, (ii) number of days with restricted
activity attributed to back pain, and (iii) whether medication was
used for back pain over the previous four weeks; economic data;
preference for treatment at baseline; and, for the yoga group, class
attendance and continued use of yoga at home or elsewhere.3.7. Bias
Randomisation eliminates selection bias. However there are
other sources of bias we need to avoid. When patients do not
receive their preferred treatment in randomised trials there may be
difﬁculties with patient recruitment and scientiﬁc problems with
bias.15 For example, bias may occur when patients are aware of
a treatment not available to them and comply poorly with the
standard treatment or withdraw from the trial completely,
commonly known as resentful demoralisation. The absence of
these patients from trials may restrict generalisation of the results
as participants may not be representative. To control for patient
preferences we propose to ask the participants at baseline their
treatment preferences. This design allows us to control for the
impact of patient preference in the analysis. In addition, we will
offer the control participants a one-off yoga class at the end of the
study to help minimise resentful demoralisation.
Loss to follow-up is likely to lead to biased estimates of inter-
vention effect. We will try to avoid bias due to attrition by carefully
following up the participants in both groups. We will phone
participants who fail to complete questionnaires after a second
reminder to ask if they would be willing to complete the RDQ over
the phone. The ﬁnal follow-up questionnaire will be accompanied
by a £5 incentive to complete the questionnaire in order to reduce
attrition rates. We anticipate a 20% loss to follow-up in this trial,
and will implement procedures to minimise loss to follow-up and
patient withdrawal, and where possible wewill collect information
on reasons for patient withdrawal.Non-adherence to the intervention is likely to reduce its
potential effectiveness, and provide a conservative estimate of
intervention effect compared to what would be expected if there
was full compliance. In the UK BEAM trial1 compliance was 92% for
manipulation and 63% for exercise. We anticipate that compliance
in this trial will lie somewhere between these. In the Sherman trial2
of yoga for LBP, the median attendance was 9/12 classes. Further-
more, attendance to yoga was greater than attendance to exercise
classes.
3.8. Sample size
The UK BEAM trial1 found that a change in the RDQ score of 1.57
points was a cost-effective difference. Assuming a standard devia-
tion of 4 points, (the UK BEAM sample size was based on an
assumed population standard deviation of 4 points for this ques-
tionnaire) this results in a standardised effect size (difference in
means/standard deviation) of 0.39. To detect this effect size,
assuming 80% power, an independent samples t-test and a 2-sided
5% signiﬁcance level would require 105 participants per group, 210
in total. Allowing for 20% loss to follow-up we require a total of 262
participants (131 per group).
4. Analysis
4.1. Statistical analysis plan
All analyses will be conducted on an intention to treat basis,
including all randomised patients in the groups to which they were
randomised. Analyses will be conducted using 2-sided signiﬁcance
tests at the 5% signiﬁcance level. The statistician conducting the
analyses will remain blind to treatment group and data will only be
unblinded once all data summaries and analyses are completed.
4.2. Baseline data
All baseline data will be summarised by treatment group.
Baseline data will be described descriptively. No formal statistical
comparisons will be undertaken.
4.3. Follow-up data
The primary outcome will be the RDQ scores. These will be
summarised descriptively (mean, SD, median, minimum and
maximum) at each time point by treatment group. The primary
analysis will compare the yoga and control groups at 3months. This
time point has been chosen as it corresponds to the end of the yoga
classes. A secondary analysis will compare the two groups at
12 months to assess if any differences between groups have been
maintained over time. Reasons for missing outcome data will be
explored by descriptively comparing the baseline characteristics of
participants who do and do not return their 3, 6 or 12 month
questionnaires.
A repeated measures mixed model (SAS proc mixed) will be
used to compare the treatment groups. This will treat yoga classes
as a random effect to account for clustering effects within centres.
The outcome modelled will be the Roland Morris score at 3, 6 and
12 months and the model will include the baseline score, age,
gender, duration of back pain, treatment group, and time. An
interaction term assessing whether the difference between the
treatment groups changes over time will also be assessed for
inclusion in the model.
Different covariance patterns for the repeated outcome
measures will be explored and the most appropriate structure will
be used. The difference in mean scores between the treatment
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95% conﬁdence interval (CI) will be estimated from this model.
Estimates of the difference between treatment group means at
12months and corresponding 95% CI will also be obtained from this
model. Model assumptions will be checked (normal distribution
and constant variance) and, if necessary, data will be transformed
prior to analysis if this improves the model ﬁt.
An additional exploratory analysis will be used to investigate the
effect of compliance with treatment using a CACE (complier
average causal effect) analysis. Participants complying with the
yoga course will be deﬁned as those who attend at least 3 out of
the ﬁrst 6 classes and at least any other 3 classes (at least 6 in total).
The numbers of compliant participants using these criteria, and
further details of attendance (numbers attending each class,
reported by centre) will be summarised.
Secondary outcomes will be summarised and analysed in the
same way as the primary outcome. The SF-12 will be summarised
for all components. To minimise multiple testing, only the overall
physical component score and mental component score will be
analysed, using the same analysis methods as for the primary
outcome.
4.4. Adverse events
The number of adverse events experienced by each participant
and total number of events overall will be summarised for each
treatment group. The severity of the event and whether or not it
was considered related to treatment will also be summarised.
4.5. Economic analysis plan
The economic analysis will compare the costs and outcomes
in terms of quality adjusted life years (QALYs) as weighted by the
EQ-5D. Costs will be assessed from the viewpoint of both the NHS
and society. We will undertake a cost-effectiveness analysis by
comparing costs associated to resource use between the two
groups and setting this against any treatment beneﬁt. The time
horizon for the analysis is 1 year after recruitment. This way, costs
or QALYs will not be discounted. There will be a baseline assess-
ment followed by an assessment at 3 months, 6 months and
12 months that will collect data on quality of life, resource use data
and, for the yoga group, continued use of yoga at home or
elsewhere.
Data for the resource use component of the economic analysis
will be collected from the patients, such as visits to their GP and
visits to other health providers (e.g. physiotherapy), both private
and within the NHS and whether related to back pain or not. Unit
costs will be assigned to resource use observed for each individual,
in order to estimate total costs. Unit costs will come from a variety
of national sources including published sources e.g. GP visits from
the Personal Social Services Research Unit16 (PSSRU).
The EQ-5D proﬁles generated for each patient will be scored
using the set of UK ‘social preference weights’ supplied by the
EuroQol group, based on the general population scores for the
health states deﬁned.17 Mean scores and measures of dispersion
will be calculated for both groups. QALYs will be calculated using
area under the curve analysis based on the social preference
weights. To avoid bias we will adjust for differences in baseline
EQ-5D scores18 as a measure of baseline severity to account for any
differential recruitment.
To meet the needs of decision-makers, the focus will be on esti-
mating expected values for costs and outcomes (QALY) of the health
technologies. The use of a regression method for CEA has many
advantages19,20: possible heterogeneity sources can be evaluated
through the incorporation of stratiﬁcation or prognostic variablesand the hierarchical nature of the data in relation to multi-centre
data collection or different carers applying the treatment can be
accounted for. Moreover, it allows the identiﬁcation and quantiﬁ-
cation of subgroup effects (e.g. socio-demographic variables as sex,
age or ethnic group; or prognostic factors as length of illness).
As the recruitment will be based on different yoga teachers at
ﬁve sites (Cornwall, North London, West London, Manchester and
York) a multilevel net beneﬁt regression approach will be used.21
The net monetary beneﬁt for each participant is calculated by
subtracting the additional cost from the additional effect valued in
pounds. Relevant covariates (those that will be included in the
statistical analysis, including baseline utility score) will be consid-
ered in the regression. Subgroup analysis focussing on compliance
will be undertaken as speciﬁed in the clinical analysis plan. Addi-
tionally, if deemed necessary, the impact of missing data will be
evaluated in sensitivity analysis.4.6. Uncertainty assessment and sensitivity analysis
Due to sampling, costs and QALYs are estimated with uncer-
tainty. This uncertainty will be interpreted through both bootstrap
and graphical methods.22,23 For such, cost-effectiveness planes and
cost-effectiveness acceptability curves (CEAC) will be plotted. The
CEAC will show the probability of the low back pain management
including yoga being cost-effective in relation to the reference
management strategy, for different thresholds the decision maker
may be willing to pay for additional beneﬁt (QALY). A series of
sensitivity analysis will be conducted to explore the variability in
estimating cost-effectiveness. For instance, alternative imputation
methods for missing data and various assumptions of costs.5. Ethical review
Ethical approval for this trial was obtained from Leeds East
Research Ethics Committee, UK. The investigators will ensure that
the trial will be conducted in compliance with ethical guidelines as
set out by this committee, and in line with recommended good
clinical practice (GCP) guidelines.
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